DCC2437 |
Gw305178x |
Novel inhibitor of CDK |
|
DCC2438 |
Gw3333 |
Novel selective and soluble inhibitor of tumor necrosis factor-alpha converting enzyme (TACE) |
|
DCC2439 |
gw409544 |
Potent and selective full agonist for peroixisome proliferator-activated receptor-alpha |
|
DCC2440 |
Gw440139a |
Novel potent RET kinase inhibitor |
|
DCC2441 |
gw441756 Hydrochloride |
Potent TrkA kinase inhibitor |
|
DCC2442 |
Gw493838 |
Novel agonist at the adenosine A1 receptor |
|
DCC2443 |
gw5638 |
Orally active, nonsteroidal tamoxifen derivative and a ligand for the estrogen receptors (ERs), steroid receptor members of the nuclear receptor superfamily of transcription factors |
|
DCC2444 |
Gw568377a |
Inhibitor of Mer Kinase, also inhibiting EGFR |
|
DCC2445 |
Gw612286x |
Novel VEGFR inhibitor, also a moderate inhibitor of BET proteins with an IC 50 value of 4.6 μM for BRD4(1) |
|
DCC2446 |
Gw648495 |
Potent inhibitor of PfDHODH, showing greater than 4,000-fold selectivity for the malarial enzyme |
|
DCC2447 |
gw693881a |
Novel inhibitor of EGFR |
|
DCC2448 |
Gw701427a |
Novel inhibitor of firefly luciferase derived from Photinus pyralis (FLuc), the most widely used luciferase |
|
DCC2449 |
Gw780056x |
Selective cyclin dependent kinase inhibitor; Inhibitor of Yes1 kinase; Inhibitor of binding or entry into cells for Lassa Virus |
|
DCC2450 |
gw7845 |
Selective agonist of peroxisome proliferator-activated receptor-γ (PPARγ) |
|
DCC2451 |
Gw807982x |
Potent and selective inhibitor of glycogen synthase kinase 3 (GSK3) |
|
DCC2452 |
Gw809897x |
Novel and potent inhibitor of VEGFR2 tyrosine kinase, non-selectivey inhibiting AURKA and AURKB |
|
DCC2453 |
Gw827106x |
Potent GSK-3 inhibitor, highly selective over CDK-2 |
|
DCC2454 |
Gw833373x |
Novel Inhibitor of GSK3beta |
|
DCC2455 |
Gw837016x |
Novel inhibitor of mitosis and cytokinesis in T. brucei which causes human African trypanosomiasis (HAT) |
|
DCC2456 |
Gw844520 |
Novel potent and selective inhibitor of the cytochrome bc1 complex of mitochondrial electron transport in P. falciparum |
|
DCC2457 |
gw853606 |
Novel polo-like kinase (PLK1) inhibitor |
|
DCC2458 |
Gw856804x |
Novel NAD+-competitive Sirt2 inhibitor |
|
DCC2459 |
Gwl-78 |
Novel modulator of NF-Y transcription, inhibiting the binding of NF-Y to DNA, blocking cellular proliferation and cell cycle progression, interacting with a variety of CCAAT-containing promoters leading to p53-independent cell cycle arrest |
|
DCC2460 |
Gx-395 |
Novel inhibitor of Nav1.7 |
|
DCC2461 |
Gx-585 |
Novel potent inhibitor of NaV1.7 and highly selective against NaV1.5, having limited selectivity against NaV1.1 and NaV1.2 |
|
DCC2462 |
Gx-629 |
GX-936 analog, antagonist of voltage-gated sodium 1.7 (Nav1.7) channels |
|
DCC2463 |
Gyki-53655 |
AMPA antagonist |
|
DCC2464 |
Gyramide A |
Novel bacterial DNA gyrase inhibitor, exhibiting antimicrobial activity and inhibiting bacterial cell division |
|
DCC2465 |
H-0104 Dihydrochloride |
Novel Rho-associated coiled coil-formed protein kinase (ROCK) inhibitor, exerting strong intraocular pressure (IOP)-lowering effects into the eyes of monkeys |
|
DCC2466 |
H-0106 Dihydrochloride |
Novel Rho-associated coiled coil-formed protein kinase (ROCK) inhibitor, exerting strong intraocular pressure (IOP)-lowering effects into the eyes of monkeys |
|